Tokyo, Japan

Mari Sugita



 

Average Co-Inventor Count = 8.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2013-2014

Loading Chart...
Loading Chart...
Loading Chart...
4 patents (USPTO):

Title: Innovator Spotlight: Mari Sugita - Pioneering Solutions in Pharmaceuticals

Introduction:

Mari Sugita, a distinguished inventor based in Tokyo, Japan, has made significant contributions to the field of pharmaceuticals through his innovative patents and research endeavors. With an impressive portfolio of four patents, Sugita has demonstrated a keen understanding of scientific principles and a passion for developing novel solutions to medical challenges.

Latest Patents:

Among Sugita's latest patents is the groundbreaking discovery of Substituted imidazo[1,5-A]quinoxalin-4-ones, compounds that exhibit PDE9-inhibitory action. These compounds have shown promise in preventing and treating storage dysfunction, voiding dysfunction, and various bladder/urethral diseases. Additionally, Sugita's research led to the identification of a Pyrazoloquinoline compound with PDE9-inhibiting action, further expanding the possibilities for therapeutic interventions in urological conditions.

Career Highlights:

Currently employed at Astellas Pharma GmbH, a leading pharmaceutical company, Sugita continues to drive innovation in drug development. His expertise in pharmacology and medicinal chemistry has been instrumental in advancing the company's research initiatives and product pipelines. Sugita's dedication to improving patient outcomes underscores his commitment to making a positive impact in healthcare.

Collaborations:

Sugita has had the privilege of collaborating with esteemed colleagues such as Hiroyuki Kaizawa and Hirofumi Yamamoto. Together, they have synergized their diverse skill sets and knowledge to tackle complex scientific challenges, paving the way for new discoveries and breakthroughs in pharmaceutical science. Through effective teamwork and collaboration, Sugita and his coworkers have exemplified the power of collective intelligence in driving innovation.

Conclusion:

In conclusion, Mari Sugita stands out as a visionary inventor whose pioneering work in pharmaceuticals has the potential to transform the landscape of medical treatment. His dedication to pushing the boundaries of scientific knowledge and his commitment to excellence serve as inspiration for aspiring inventors and researchers in the field. Sugita's contributions highlight the importance of innovation in addressing unmet medical needs and improving global health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…